Care of haematology patients in a COVID-19 epidemic.
Willan J. et al, (2020), Br J Haematol, 189, 241 - 243
Disease progression in patients with essential thrombocythaemia receiving anagrelide within a single institution
Gray N. et al, (2020), BRITISH JOURNAL OF HAEMATOLOGY, 189, 76 - 77
Escalated BEACOPDac as first line therapy in 100 Hodgkin lymphoma patients reduces red cell transfusion requirements and may shorten time to menstrual period recovery whilst maintaining efficacy compared to escalated BEACOPP
Santarsieri A. et al, (2020), BRITISH JOURNAL OF HAEMATOLOGY, 189, 97 - 99
Quality of Life with weekly platinum-based chemotherapy in newly diagnosed Ovarian Cancer: the ICON8 phase III randomised controlled clinical trial
BLAGDEN S. et al, (2020), The Lancet Oncology
Red cell transfusion in outpatients with myelodysplastic syndromes: a feasibility and exploratory randomised trial.
Stanworth SJ. et al, (2020), Br J Haematol, 189, 279 - 290
Treatment of classical Hodgkin lymphoma in young adults aged 18-30 years with a modified paediatric Hodgkin lymphoma protocol. Results of a multicentre phase II clinical trial (CRUK/08/012).
Townsend W. et al, (2020), Br J Haematol, 189, 128 - 132
Heterogeneous disease-propagating stem cells in juvenile myelomonocytic leukemia.
Louka E. et al, (2020), BioRix
Single-cell analyses reveal aberrant pathways for megakaryocyte-biased hematopoiesis in myelofibrosis and identify mutant clone-specific targets
ROBERTS I. et al, (2020), Molecular Cell
A physician survey on the application of the British Society for Haematology guidelines for the diagnosis and management of myelofibrosis in the UK.
Harrison CN. et al, (2020), British journal of haematology, 188, e105 - e109
A Randomized Phase II Trial of Epigenetic Priming with Guadecitabine and Carboplatin in Platinum-resistant, Recurrent Ovarian Cancer.
Oza AM. et al, (2020), Clin Cancer Res, 26, 1009 - 1016
European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 1. epidemiology, diagnostics and prevention.
Stratigos AJ. et al, (2020), Eur J Cancer, 128, 60 - 82
European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 2. Treatment.
Stratigos AJ. et al, (2020), Eur J Cancer, 128, 83 - 102
Single-cell sequencing in hematology.
Brierley CK. and Mead AJ., (2020), Current opinion in oncology, 32, 139 - 145
What do we know about duodenal-type follicular lymphoma? From pathological definition to treatment options.
Duffles Amarante G. et al, (2020), Br J Haematol, 188, 831 - 837
Pharmacodynamic effect of tebentafusp (TCR-CD3 bispecific) on peripheral cytokines and association with overall survival in patients with advanced melanoma
Middleton MR. et al, (2020), JOURNAL OF TRANSLATIONAL MEDICINE, 18
Relationship between clinical efficacy and AEs of tebentafusp, a novel bispecific TCR-anti-CD3, in patients with advanced melanoma
Middleton MR. et al, (2020), JOURNAL OF TRANSLATIONAL MEDICINE, 18
A Phase 1 Trial of RP1: A New Oncolytic Virus Alone and in Combination with Nivolumab
Middleton M. et al, (2020), ANNALS OF SURGICAL ONCOLOGY, 27, S132 - S132